SIRT1调控Nrf2/HO-1信号通路对脓毒症诱导急性肺损伤的影响
该研究将24只雄性SD大鼠随机分为假手术组、盲肠结扎穿孔(CLP)脓毒症组、CLP+SRT1720组(CLP前2小时腹腔注射10 mg/kg SRT1720)和CLP+EX527组(CLP前2小时腹腔注射10 mg/kg EX527),每组6只,造模24小时后取肺组织检测。结果显示CLP组肺损伤加重、Smith评分及炎症因子、氧化应激指标升高,SIRT1、Nrf2、HO-1表达降低;SRT1720可显著减轻上述改变,EX527则进一步加重肺损伤并抑制SIRT1/Nrf2/HO-1表达。作者结论认为SIRT1可通过调控Nrf2/HO-1通路激活、上调下游抗氧化酶表达、减轻氧化应激损伤,从而缓解脓毒症诱导的大鼠急性肺损伤。
要点
- CLP脓毒症大鼠肺组织SIRT1、Nrf2、HO-1的mRNA和蛋白表达均显著降低,同时肺损伤评分、炎症因子和氧化应激指标显著升高。
- CLP前2小时腹腔注射SRT1720 10 mg/kg可显著降低CLP大鼠Smith评分(2.83±0.75 vs. 5.67±0.52)及TNF-α、IL-6、IL-1β水平(均P<0.05)。
- SRT1720组SOD活性、GSH含量升高,MDA、8-OHdG含量降低,SIRT1、Nrf2、HO-1的mRNA和蛋白表达升高(均P<0.05)。
- CLP前2小时腹腔注射EX527 10 mg/kg则使Smith评分升至8.00±0.89(vs. CLP组5.67±0.52),炎症因子升高、抗氧化指标降低(均P<0.05)。
- 作者结论认为SIRT1通过调控Nrf2/HO-1通路激活、上调下游抗氧化酶表达、减轻氧化应激损伤,从而缓解脓毒症诱导的大鼠急性肺损伤。
适用人群与场景
- 雄性Sprague-Dawley(SD)大鼠,共24只,随机分为4组,每组6只。
- 研究对象为盲肠结扎穿孔(CLP)诱导的脓毒症急性肺损伤大鼠模型。
处置流程与药物剂量
- CLP+SRT1720组:CLP前2小时腹腔注射SRT1720 10 mg/kg。
- CLP+EX527组:CLP前2小时腹腔注射EX527 10 mg/kg。
- 各组大鼠于造模24小时后处死并取肺组织检测。
研究设计与关键结果
- 研究类型为动物实验,24只雄性SD大鼠随机分为假手术组、CLP组、CLP+SRT1720组、CLP+EX527组,每组6只。
- CLP组肺组织严重损伤,肺泡间隔增宽、大量炎症细胞浸润、可见肺毛细血管充血;Smith评分及TNF-α、IL-6、IL-1β、MDA、8-OHdG水平显著升高,SOD、GSH、SIRT1、Nrf2、HO-1水平显著降低。
- 与CLP组相比,CLP+SRT1720组Smith评分2.83±0.75 vs. 5.67±0.52、TNF-α(ng/L)36.78±5.36 vs. 66.99±5.44、IL-6(ng/L)23.97±3.76 vs. 45.70±4.16、IL-1β(ng/L)16.76±1.39 vs. 39.64±2.59均显著降低(均P<0.05)。
- 与CLP组相比,CLP+SRT1720组SOD(kU/g)115.88±3.31 vs. 101.65±1.09、GSH(μmol/g)8.42±0.81 vs. 5.74±0.46升高(均P<0.05),MDA(μmol/g)5.24±0.33 vs. 9.86±0.66、8-OHdG(ng/L)405.76±8.54 vs. 647.12±10.64降低(均P<0.05)。
- 与CLP组相比,CLP+SRT1720组SIRT1 mRNA(2-ΔΔCT)1.49±0.15 vs. 0.64±0.03、Nrf2 mRNA(2-ΔΔCT)1.19±0.08 vs. 0.84±0.02、HO-1 mRNA(2-ΔΔCT)1.80±0.41 vs. 0.64±0.11、SIRT1蛋白(SIRT1/β-actin)1.03±0.06 vs. 0.52±0.05、Nrf2蛋白(Nrf2/β-actin)1.14±0.10 vs. 0.63±0.05、HO-1蛋白(HO-1/β-actin)1.01±0.11 vs. 0.73±0.03均升高(均P<0.05)。
- 与CLP组相比,CLP+EX527组肺损伤更重,Smith评分8.00±0.89 vs. 5.67±0.52、TNF-α(ng/L)87.15±4.23 vs. 66.99±5.44、IL-6(ng/L)66.79±2.93 vs. 45.70±4.16、IL-1β(ng/L)58.99±2.12 vs. 39.64±2.59均显著升高(均P<0.05)。
- 与CLP组相比,CLP+EX527组SOD(kU/g)72.84±3.85 vs. 101.65±1.09、GSH(μmol/g)3.30±0.67 vs. 5.74±0.46降低(均P<0.05),MDA(μmol/g)14.14±0.70 vs. 9.86±0.66、8-OHdG(ng/L)927.66±11.47 vs. 647.12±10.64升高(均P<0.05)。
- 与CLP组相比,CLP+EX527组SIRT1 mRNA(2-ΔΔCT)0.40±0.07 vs. 0.64±0.03、Nrf2 mRNA(2-ΔΔCT)0.48±0.07 vs. 0.84±0.02、HO-1 mRNA(2-ΔΔCT)0.27±0.14 vs. 0.64±0.11、SIRT1蛋白(SIRT1/β-actin)0.20±0.05 vs. 0.52±0.05、Nrf2蛋白(Nrf2/β-actin)0.45±0.01 vs. 0.63±0.05、HO-1蛋白(HO-1/β-actin)0.36±0.08 vs. 0.73±0.03均降低(均P<0.05)。
证据类型、等级与局限
- 证据类型:动物实验(大鼠CLP脓毒症急性肺损伤模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论认为,在大鼠脓毒症急性肺损伤模型中,SIRT1可调控Nrf2/HO-1信号通路激活、上调下游抗氧化酶表达、减轻氧化应激损伤,从而缓解脓毒症诱导的急性肺损伤。
- 该结果为动物实验机制研究,原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate whether silence information regulator 1 (SIRT1) could regulate nuclear factor E2-related factor 2/heme oxygenase 1 (Nrf2/HO-1) signaling pathway and its role in acute lung injury (ALI) in sepsis rats.
METHODS: Twenty-four male Sprague-Dawley (SD) rats were randomly divided into sham operation group (Sham group), cecal ligation and puncture (CLP) induced sepsis group (CLP group), sepsis+SIRT1 specific agonist group (CLP+SRT1720 group,10 mg/kg SRT1720 was intraperitoneally injected 2 hours before CLP), sepsis+SIRT1 specific inhibitor group (CLP+EX527 group, 10 mg/kg EX527 was intraperitoneally injected 2 hours before CLP), with 6 rats in each group. The rats were killed 24 hours after modeling and their lung tissues were taken for pathological score (Smith score), superoxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA), 8-hydroxydeoxyguanosine (8-OHdG), tumor necrosis factor-α (TNF-α), interleukins (IL-6, IL-1β), and SIRT1, Nrf2 and HO-1 mRNA and protein expression were detected.
RESULTS: The lung tissue of the CLP group mice was severely damaged, the alveolar interval was widened and a large number of inflammatory cells infiltrated, and there was visible pulmonary capillary hyperemia. The Smith score, the levels of TNF-α, IL-6, IL-1β, MDA and 8-OHdG were significantly increased, the levels of SOD, GSH, SIRT1, Nrf2 and HO-1 were significantly decreased in CLP group. After using SIRT1 specific agonist, the lung injury in CLP+SRT1720 group was significantly alleviated compared with that in CLP group, Smith score and lung tissue TNF-α, IL-6, and IL-1β levels were significantly decreased [Smith score: 2.83±0.75 vs. 5.67±0.52, TNF-α (ng/L): 36.78±5.36 vs. 66.99±5.44, IL-6 (ng/L): 23.97±3.76 vs. 45.70±4.16, IL-1β (ng/L): 16.76±1.39 vs. 39.64±2.59, all P < 0.05], SOD activity and GSH content increased [SOD (kU/g): 115.88±3.31 vs. 101.65±1.09, GSH (μmol/g): 8.42±0.81 vs. 5.74±0.46, both P < 0.05], MDA and 8-OHdG contents decreased [MDA (μmol/g): 5.24±0.33 vs. 9.86±0.66, 8-OHdG (ng/L): 405.76±8.54 vs. 647.12±10.64, both P < 0.05], the mRNA and protein expressions of SIRT1, Nrf2 and HO-1 were increased [SIRT1 mRNA (2-ΔΔCT): 1.49±0.15 vs. 0.64±0.03, Nrf2 mRNA (2-ΔΔCT): 1.19±0.08 vs. 0.84±0.02, HO-1 mRNA (2-ΔΔCT): 1.80±0.41 vs. 0.64±0.11, SIRT1 protein (SIRT1/β-actin): 1.03±0.06 vs. 0.52±0.05, Nrf2 protein (Nrf2/β-actin): 1.14±0.10 vs. 0.63±0.05, HO-1 protein (HO-1/β-actin): 1.01±0.11 vs. 0.73±0.03, all P < 0.05]. The lung injury in CLP+EX527 group was more severe than that in CLP group, Smith score and lung tissue TNF-α, IL-6, IL-1β levels were significantly increased [Smith score: 8.00±0.89 vs. 5.67±0.52, TNF-α (ng/L): 87.15±4.23 vs. 66.99±5.44, IL-6 (ng/L): 66.79±2.93 vs. 45.70±4.16, IL-1β (ng/L): 58.99±2.12 vs. 39.64±2.59, all P < 0.05], SOD activity and GSH content decreased [SOD (kU/g): 72.84±3.85 vs. 101.65±1.09, GSH (μmol/g): 3.30±0.67 vs. 5.74±0.46, both P < 0.05], the contents of MDA and 8-OHdG were increased [MDA (μmol/g): 14.14±0.70 vs. 9.86±0.66, 8-OHdG (ng/L): 927.66±11.47 vs. 647.12±10.64, both P < 0.05], the mRNA and protein expressions of SIRT1, Nrf2 and HO-1 were decreased [SIRT1 mRNA (2-ΔΔCT): 0.40±0.07 vs. 0.64±0.03, Nrf2 mRNA (2-ΔΔCT): 0.48±0.07 vs. 0.84±0.02, HO-1 mRNA (2-ΔΔCT): 0.27±0.14 vs. 0.64±0.11, SIRT1 protein (SIRT1/β-actin): 0.20±0.05 vs. 0.52±0.05, Nrf2 protein (Nrf2/β-actin): 0.45±0.01 vs. 0.63±0.05, HO-1 protein (HO-1/β-actin): 0.36±0.08 vs. 0.73±0.03, all P < 0.05].
CONCLUSIONS: In the rat model of ALI induced by sepsis, SIRT1 can regulate the activation of Nrf2/HO-1 signaling pathway, upregulate the expression of downstream antioxidant enzymes, reduce oxidative stress injury, and then alleviate the ALI induced by sepsis in rats.
参考来源
- Zhang Y, Chen M, Wang Y, et al. [Effect of SIRT1 regulating Nrf2/HO-1 signaling pathway on sepsis-induced acute lung injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916335. doi:10.3760/cma.j.cn121430-20220815-00745
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。